Oppenheimer initiates coverage of MEIP with "outperform." Stock up 9%
Oppenheimer initiated coverage on MEI Pharma Inc MEIP with an Outperform rating. The price target for MEI Pharma is set to $6.50. MEI Pharma shares closed at $1.67 on Wednesday.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.